XML 29 R22.htm IDEA: XBRL DOCUMENT v3.25.2
Stock Based Compensation
3 Months Ended
May 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock Based Compensation

12. Stock Based Compensation

The Company grants stock options, restricted stock and restricted stock units (“RSUs”) to key executives and managerial employees and non-employee directors. At May 31, 2025, the Company had one stock option plan, the 2021 Long-Term Incentive Plan of Ennis, Inc., adopted by the Board April 16, 2021 and affirmed by vote of the shareholders July 15, 2021 (the “Plan”). The plan authorized 1,033,648 shares of common stock for awards and expires June 30, 2031 and all unissued stock will expire on that date. May 31, 2025, the Company has 290,261 shares of unissued common stock reserved under the Plan for issuance. The exercise price of each stock option granted under the Plan equals a referenced price of the Company’s common stock as reported on the New York Stock Exchange on the date of grant, and an option’s maximum term is ten years. Stock options and restricted stock may be granted at different times during the year and vest ratably over various periods, from grant date up to five years. The Company uses treasury stock to satisfy option exercises and restricted stock awards.

The Company recognizes compensation expense for stock options and restricted stock grants based on the grant date fair value of the award for stock options, restricted stock grants and RSUs on a straight-line basis over the requisite service period. The estimated number of shares to be achieved for performance based RSUs is updated each reporting period. For the three months ended May 31, 2025 and May 31, 2024, the Company included in selling, general and administrative expenses, compensation expense related to stock-based compensation of $0.7 million and $1.8 million, respectively.

Stock Options

The Company had the following stock option activity for the three months ended May 31, 2025.

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

Number

 

 

Average

 

 

Remaining

 

 

Intrinsic

 

 

 

of Shares

 

 

Exercise

 

 

Contractual

 

 

Value(a)

 

 

 

(exact quantity)

 

 

Price

 

 

Life (in years)

 

 

(in thousands)

 

Outstanding at March 1, 2025

 

 

31,251

 

 

$

19.88

 

 

 

9.0

 

 

 

 

Granted

 

 

10,809

 

 

 

17.27

 

 

 

 

 

 

 

Terminated

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(2,500

)

 

 

17.27

 

 

 

 

 

 

 

Outstanding at May 31, 2025

 

 

39,560

 

 

$

19.33

 

 

 

8.3

 

 

$

11.7

 

Exercisable at May 31, 2025

 

 

26,222

 

 

$

19.05

 

 

 

8.5

 

 

$

11.7

 

 

A summary of the status of the Company’s unvested stock options at May 31, 2025 and the changes during the three months ended May 31, 2025 are presented below:

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

Number

 

Grant Date

 

 

of Options

 

Fair Value

Unvested at March 1, 2025

 

26,669

 

2.47

New grants

 

10,809

 

2.41

Vested

 

(24,140)

 

2.44

Forfeited

 

 

Unvested at May 31, 2025

 

13,338

 

2.47

 

 

As of May 31, 2025, there was $0.1 million of unrecognized compensation cost related to unvested stock options granted under the Plan. The weighted average remaining requisite service period of the unvested stock options was 0.9 years.

 

Restricted Stock

The following activity occurred with respect to the Company’s restricted stock awards for the three months ended May 31, 2025:

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

Number of

 

 

Grant Date

 

 

Shares

 

 

Fair Value

 

Outstanding at March 1, 2025

 

41,667

 

 

$

21.68

 

Granted

 

 

 

 

 

Terminated

 

 

 

 

 

Vested

 

(667

)

 

 

17.58

 

Outstanding at May 31, 2025

 

41,000

 

 

$

21.68

 

As of May 31, 2025, the total remaining unrecognized compensation cost related to unvested restricted stock was approximately $1.1 million. The weighted average remaining requisite service period of the unvested restricted stock awards was 1.5 years.

Restricted Stock Units

During the three months ended May 31, 2025, no performance-based or time-based RSUs were granted under the Plan. The fair value of the time-based RSUs was estimated based on the fair market value of the Company’s stock on the date of grant of $19.43 per unit. The fair value of the performance-based RSUs, using a Monte Carlo valuation model, was $19.97 per unit. The performance measures include a threshold, target and maximum performance level providing the grantees an opportunity to receive more or less shares than targeted depending on actual financial performance of the Company. The award will be based on the Company’s return on equity, EBITDA and adjusted for the Company’s Relative Shareholder Return as measured against a defined peer group. Holders of RSUs receive cash dividends equal to the dividends we declare and pay on our common stock, which are included in dividends paid in the Condensed Consolidated Financial Statements.

The performance-based RSUs vest on the third anniversary from the date of grant and the time-based RSUs vest ratably over three years from the date of grant.

The following activity occurred with respect to the Company’s restricted stock units for the three months ended May 31, 2025:

 

 

Time-based

 

 

Performance-based

 

 

 

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Average

 

 

Number of

 

 

Grant Date

 

 

Number of

 

 

Grant Date

 

 

Shares

 

 

Fair Value

 

 

Shares

 

 

Fair Value

 

Outstanding at March 1, 2025 (1)

 

101,961

 

 

$

19.43

 

 

 

198,827

 

 

$

19.97

 

Granted

 

 

 

 

 

 

 

 

 

 

 

Change due to performance achievement

 

 

 

 

 

 

 

 

 

 

 

Terminated

 

(5,403

)

 

 

19.43

 

 

 

 

 

 

 

Vested

 

(28,582

)

 

 

19.43

 

 

 

 

 

 

 

Outstanding at May 31, 2025

 

67,976

 

 

$

19.43

 

 

 

198,827

 

 

$

19.97

 

(1) The number of shares of time-based grants may, upon vesting, convert 50% into common stock and the remaining 50% into two incentive stock options for each RSU with an exercise price equal to the closing price of the Company's stock on that date for employees who have not met their stock ownership requirements. The number of shares of performance-based grants includes an estimate 55,037 of additional RSUs at the maximum achievement level of 130% of target payout. Actual shares that may be issued can range from 0% to 130% of target.

 

As of May 31, 2025, the total remaining unrecognized compensation cost of time-based RSUs was approximately $2.3 million over a weighted average remaining requisite service period of 1.9 years. As of May 31, 2025, the total remaining unrecognized compensation of performance-based RSUs was approximately $5.3 million over a weighted average remaining requisite service period of 1.9 years.